231 related articles for article (PubMed ID: 20081103)
1. Comparative evaluation of serum markers in pulmonary sarcoidosis.
Miyoshi S; Hamada H; Kadowaki T; Hamaguchi N; Ito R; Irifune K; Higaki J
Chest; 2010 Jun; 137(6):1391-7. PubMed ID: 20081103
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
4. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis.
Janssen R; Sato H; Grutters JC; Bernard A; van Velzen-Blad H; du Bois RM; van den Bosch JM
Chest; 2003 Dec; 124(6):2119-25. PubMed ID: 14665489
[TBL] [Abstract][Full Text] [Related]
5. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
Grutters JC; Fellrath JM; Mulder L; Janssen R; van den Bosch JM; van Velzen-Blad H
Chest; 2003 Jul; 124(1):186-95. PubMed ID: 12853522
[TBL] [Abstract][Full Text] [Related]
7. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
[TBL] [Abstract][Full Text] [Related]
8. Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis.
Prior C; Barbee RA; Evans PM; Townsend PJ; Primett ZS; Fyhrquist F; Grönhagen-Riska C; Haslam PL
Eur Respir J; 1990 Nov; 3(10):1146-54. PubMed ID: 1965306
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.
Kitaichi N; Ariga T; Kase S; Yoshida K; Namba K; Ohno S
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):433-7. PubMed ID: 16133026
[TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.
Tsutsumi T; Nagai S; Imai K; Setoyama Y; Uchiyama T; Izumi T
Sarcoidosis; 1994 Sep; 11(2):102-9. PubMed ID: 7809492
[TBL] [Abstract][Full Text] [Related]
11. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis.
Rothkrantz-Kos S; van Dieijen-Visser MP; Mulder PG; Drent M
Clin Chem; 2003 Sep; 49(9):1510-7. PubMed ID: 12928233
[TBL] [Abstract][Full Text] [Related]
12. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Kunitake R; Kuwano K; Yoshida K; Maeyama T; Kawasaki M; Hagimoto N; Hara N
Respiration; 2001; 68(5):488-95. PubMed ID: 11694811
[TBL] [Abstract][Full Text] [Related]
13. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
Wieland CW; Vogl T; Ordelman A; Vloedgraven HG; Verwoolde LH; Rensen JM; Roth J; Boer J; Hessels J
Br J Dermatol; 2013 Jun; 168(6):1252-8. PubMed ID: 23320892
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
[TBL] [Abstract][Full Text] [Related]
15. Levels of transferrin in bronchoalveolar lavage fluid in sarcoidosis.
Shigemura M; Nasuhara Y; Konno S; Hattori T; Shimizu C; Matsuno K; Nishimura M
Lung; 2010 Apr; 188(2):151-7. PubMed ID: 20066543
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
17. [Soluble interleukin 2 receptor (SIL-2R) in bronchoalveolar lavage fluid (BALF) of patients with sarcoidosis and atopic bronchial asthma].
Jankowska R; Passowicz-Muszyńska E; Gołecki M; Krasnowska M
Pneumonol Alergol Pol; 2002; 70(7-8):347-52. PubMed ID: 12708075
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Ia+ T lymphocytes in bronchoalveolar lavage fluid in pulmonary sarcoidosis.
Suzuki K; Tamura N; Iwase A; Dambara T; Kira S
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):707-12. PubMed ID: 8810609
[TBL] [Abstract][Full Text] [Related]
19. Elevated alpha-defensin levels in plasma of patients with pulmonary sarcoidosis.
Ashitani J; Matsumoto N; Nakazato M
Respirology; 2007 May; 12(3):339-45. PubMed ID: 17539836
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory proteins in bronchoalveolar lavage fluid. A comparative analysis of pigeon breeders' disease, sarcoidosis and idiopathic pulmonary fibrosis.
Reynolds SP; Jones KP; Edwards JH; Davies BH
Sarcoidosis; 1989 Sep; 6(2):125-34. PubMed ID: 2602684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
